FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890235955> ?p ?o ?g. }

• W2890235955 endingPage "2527" @default.
• W2890235955 startingPage "2520" @default.
• W2890235955 abstract "Treatment change following a genetic diagnosis of MODY is frequently indicated, but little is known about the factors predicting future treatment success. We therefore conducted the first prospective study to determine the impact of a genetic diagnosis on individuals with GCK-, HNF1A- or HNF4A-MODY in the UK, and to identify clinical characteristics predicting treatment success (i.e. HbA1c ≤58 mmol/mol [≤7.5%]) with the recommended treatment at 2 years. This was an observational, prospective, non-selective study of individuals referred to the Exeter Molecular Genetic Laboratory for genetic testing from December 2010 to December 2012. Individuals from the UK with GCK- or HNF1A/HNF4A-MODY who were not on recommended treatment at the time of genetic diagnosis, and who were diagnosed below the age of 30 years and were currently aged less than 50 years, were eligible to participate. A total of 44 of 58 individuals (75.9%) changed treatment following their genetic diagnosis. Eight individuals diagnosed with GCK-MODY stopped all diabetes medication without experiencing any change in HbA1c (49.5 mmol/mol [6.6%] both before the genetic diagnosis and at a median of 1.25 years’ follow-up without treatment, p = 0.88). A total of 36 of 49 individuals (73.5%) diagnosed with HNF1A/HNF4A-MODY changed treatment; however, of the 21 of these individuals who were being managed with diet or sulfonylurea alone at 2 years, only 13 (36.1% of the population that changed treatment) had an HbA1c ≤58 mmol/mol (≤7.5%). These individuals had a shorter diabetes duration (median 4.6 vs 18.1 years), lower HbA1c (58 vs 73 mmol/mol [7.5% vs 8.8%]) and lower BMI (median 24.2 vs 26.0 kg/m2) at the time of genetic diagnosis, compared with individuals (n = 23/36) with an HbA1c >58 mmol/mol (>7.5%) (or <58 mmol/mol [<7.5%] on additional treatment) at the 2 year follow-up. Overall, 64% (7/11) individuals with a diabetes duration of ≤11 years and an HbA1c of ≤69 mmol/mol (≤8.5%) at time of the genetic test achieved good glycaemic control (HbA1c ≤58 mmol/mol [≤7.5%]) with diet or sulfonylurea alone at 2 years, compared with no participants with a diabetes duration of >11 years and an HbA1c of >69 mmol/mol (>8.5%) at the time of genetic diagnosis. In participants with GCK-MODY, treatment cessation was universally successful, with no change in HbA1c at follow-up. In those with HNF1A/HNF4A-MODY, a shorter diabetes duration, lower HbA1c and lower BMI at genetic diagnosis predicted successful treatment with sulfonylurea/diet alone, supporting the need for early genetic diagnosis and treatment change. Our study suggests that, in individuals with HNF1A/HNF4A-MODY with a longer duration of diabetes (>11 years) at time of genetic test, rather than ceasing current treatment, a sulfonylurea should be added to existing therapy, particularly in those who are overweight or obese and have a high HbA1c." @default.
• W2890235955 created "2018-09-27" @default.
• W2890235955 creator A5017255526 @default.
• W2890235955 creator A5060736941 @default.
• W2890235955 creator A5073846514 @default.
• W2890235955 creator A5084653587 @default.
• W2890235955 creator A5087774397 @default.
• W2890235955 creator A5088121581 @default.
• W2890235955 creator A5090739125 @default.
• W2890235955 creator A5091056160 @default.
• W2890235955 date "2018-09-18" @default.
• W2890235955 modified "2023-10-13" @default.
• W2890235955 title "A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin" @default.
• W2890235955 cites W1752045965 @default.
• W2890235955 cites W1925102358 @default.
• W2890235955 cites W1932876408 @default.
• W2890235955 cites W1976002091 @default.
• W2890235955 cites W1990584688 @default.
• W2890235955 cites W1996549380 @default.
• W2890235955 cites W2035266657 @default.
• W2890235955 cites W2038888939 @default.
• W2890235955 cites W2040195150 @default.
• W2890235955 cites W2048237871 @default.
• W2890235955 cites W2048945518 @default.
• W2890235955 cites W2050911510 @default.
• W2890235955 cites W2062206625 @default.
• W2890235955 cites W2073017460 @default.
• W2890235955 cites W2080680262 @default.
• W2890235955 cites W2097748435 @default.
• W2890235955 cites W2099517769 @default.
• W2890235955 cites W2101360134 @default.
• W2890235955 cites W2113865976 @default.
• W2890235955 cites W2125890548 @default.
• W2890235955 cites W2162590815 @default.
• W2890235955 cites W2168187803 @default.
• W2890235955 cites W2171294019 @default.
• W2890235955 cites W2339522457 @default.
• W2890235955 cites W2558165898 @default.
• W2890235955 cites W2612062408 @default.
• W2890235955 cites W2900001071 @default.
• W2890235955 doi "https://doi.org/10.1007/s00125-018-4728-6" @default.
• W2890235955 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6223847" @default.
• W2890235955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30229274" @default.
• W2890235955 hasPublicationYear "2018" @default.
• W2890235955 type Work @default.
• W2890235955 sameAs 2890235955 @default.
• W2890235955 citedByCount "62" @default.
• W2890235955 countsByYear W28902359552018 @default.
• W2890235955 countsByYear W28902359552019 @default.
• W2890235955 countsByYear W28902359552020 @default.
• W2890235955 countsByYear W28902359552021 @default.
• W2890235955 countsByYear W28902359552022 @default.
• W2890235955 countsByYear W28902359552023 @default.
• W2890235955 crossrefType "journal-article" @default.
• W2890235955 hasAuthorship W2890235955A5017255526 @default.
• W2890235955 hasAuthorship W2890235955A5060736941 @default.
• W2890235955 hasAuthorship W2890235955A5073846514 @default.
• W2890235955 hasAuthorship W2890235955A5084653587 @default.
• W2890235955 hasAuthorship W2890235955A5087774397 @default.
• W2890235955 hasAuthorship W2890235955A5088121581 @default.
• W2890235955 hasAuthorship W2890235955A5090739125 @default.
• W2890235955 hasAuthorship W2890235955A5091056160 @default.
• W2890235955 hasBestOaLocation W28902359551 @default.
• W2890235955 hasConcept C104317684 @default.
• W2890235955 hasConcept C126322002 @default.
• W2890235955 hasConcept C134018914 @default.
• W2890235955 hasConcept C161600633 @default.
• W2890235955 hasConcept C187212893 @default.
• W2890235955 hasConcept C188816634 @default.
• W2890235955 hasConcept C23131810 @default.
• W2890235955 hasConcept C2778854520 @default.
• W2890235955 hasConcept C2779306644 @default.
• W2890235955 hasConcept C2780323712 @default.
• W2890235955 hasConcept C2780673598 @default.
• W2890235955 hasConcept C2908647359 @default.
• W2890235955 hasConcept C2993153387 @default.
• W2890235955 hasConcept C54355233 @default.
• W2890235955 hasConcept C555293320 @default.
• W2890235955 hasConcept C71924100 @default.
• W2890235955 hasConcept C86803240 @default.
• W2890235955 hasConcept C99454951 @default.
• W2890235955 hasConceptScore W2890235955C104317684 @default.
• W2890235955 hasConceptScore W2890235955C126322002 @default.
• W2890235955 hasConceptScore W2890235955C134018914 @default.
• W2890235955 hasConceptScore W2890235955C161600633 @default.
• W2890235955 hasConceptScore W2890235955C187212893 @default.
• W2890235955 hasConceptScore W2890235955C188816634 @default.
• W2890235955 hasConceptScore W2890235955C23131810 @default.
• W2890235955 hasConceptScore W2890235955C2778854520 @default.
• W2890235955 hasConceptScore W2890235955C2779306644 @default.
• W2890235955 hasConceptScore W2890235955C2780323712 @default.
• W2890235955 hasConceptScore W2890235955C2780673598 @default.
• W2890235955 hasConceptScore W2890235955C2908647359 @default.
• W2890235955 hasConceptScore W2890235955C2993153387 @default.
• W2890235955 hasConceptScore W2890235955C54355233 @default.
• W2890235955 hasConceptScore W2890235955C555293320 @default.
• W2890235955 hasConceptScore W2890235955C71924100 @default.
• W2890235955 hasConceptScore W2890235955C86803240 @default.

• next